Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man Zhu

Showing results (131-140 of 220) with videos related to

Pageof 22
Sort By:
Bioscience Reports|August 21, 2020
miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancerHui Wang, Hui Hu, Zhenzhao Luo, et al.
Cell Insight|January 7, 2026
Hydrophobic tagging: A promising paradigm for targeted protein degradationLilan Xin, Hongli Wang, Maoze Yang, et al.
Journal of Cancer|March 21, 2018
Clinical and Diagnostic Significance of Homer1 in hepatitis B virus-induced Hepatocellular CarcinomaPing Luo, Xiaobo Feng, Wei Jing, et al.
Disease Markers|January 30, 2018
Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung CancerNandi Li, Xiao Bo Feng, Qian Tan, et al.
American Journal of Physiology. Renal Physiology|April 11, 2022
Hypoxia-inducible factor protects against acute kidney injury via the Wnt/β-catenin signaling pathwayZhi-Hui Xu, Chang Wang, Yi-Xin He, et al.
Cellular & Molecular Biology Letters|January 23, 2026
Cognitive-exercise dual-task training delays natural aging/D-galactose-induced cognitive decline in miceZi-Man Zhu, Teng-Teng Dai, Rong Zhang, et al.
Chemical Science|May 27, 2021
High frequency, calibration-free molecular measurements <i>in situ</i> in the living bodyHui Li, Shaoguang Li, Jun Dai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 21, 2024
Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective studyChang Wang, Man-Zhu Zhang, Ling-Xu Li, et al.
International Journal of Biological Macromolecules|April 7, 2025
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14Zhi-Man Zhu, Fu-Chun Huo, Ce Shi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 1, 2023
Selective Manipulation of the Mitochondria Oxidative Stress in Different Cells Using Intelligent Mesoporous Silica Nanoparticles to Activate On-Demand Immunotherapy for Cancer TreatmentXiaowei Chang, Zeren Zhu, Lin Weng, et al.
Pageof 22

Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
Bioscience Reports|August 21, 2020
miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancerHui Wang, Hui Hu, Zhenzhao Luo, et al.
Cell Insight|January 7, 2026
Hydrophobic tagging: A promising paradigm for targeted protein degradationLilan Xin, Hongli Wang, Maoze Yang, et al.
Journal of Cancer|March 21, 2018
Clinical and Diagnostic Significance of Homer1 in hepatitis B virus-induced Hepatocellular CarcinomaPing Luo, Xiaobo Feng, Wei Jing, et al.
Disease Markers|January 30, 2018
Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung CancerNandi Li, Xiao Bo Feng, Qian Tan, et al.
American Journal of Physiology. Renal Physiology|April 11, 2022
Hypoxia-inducible factor protects against acute kidney injury via the Wnt/β-catenin signaling pathwayZhi-Hui Xu, Chang Wang, Yi-Xin He, et al.
Cellular & Molecular Biology Letters|January 23, 2026
Cognitive-exercise dual-task training delays natural aging/D-galactose-induced cognitive decline in miceZi-Man Zhu, Teng-Teng Dai, Rong Zhang, et al.
Chemical Science|May 27, 2021
High frequency, calibration-free molecular measurements <i>in situ</i> in the living bodyHui Li, Shaoguang Li, Jun Dai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 21, 2024
Ultra-low-dose rituximab is effective for the treatment of patients with minimal change disease - A retrospective studyChang Wang, Man-Zhu Zhang, Ling-Xu Li, et al.
International Journal of Biological Macromolecules|April 7, 2025
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14Zhi-Man Zhu, Fu-Chun Huo, Ce Shi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 1, 2023
Selective Manipulation of the Mitochondria Oxidative Stress in Different Cells Using Intelligent Mesoporous Silica Nanoparticles to Activate On-Demand Immunotherapy for Cancer TreatmentXiaowei Chang, Zeren Zhu, Lin Weng, et al.
Pageof 22